Gilead Sciences

GILD

GILD
Gilead Sciences Stock Quote
$62.98 -$0.22 -0.3%
BATS BZX Real Time Price as of January 17, 2020, 4:30 p.m. EST View Interactive GILD Charts

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

News & Analysis: Gilead Sciences

The Fool has written over 1400 articles on Gilead Sciences.

All

Market Moves

Podcasts

Earnings










Does Amarin Have a Dark Horse Suitor?

Gilead's decision to add Vascepa to an ongoing NASH study failed to grab much attention last week. But this development is quite intriguing for several reasons.


Interactive Chart